198 related articles for article (PubMed ID: 25627085)
1. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
[TBL] [Abstract][Full Text] [Related]
2. Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44.
Lee D; Lee JW
BMB Rep; 2015 Mar; 48(3):127-8. PubMed ID: 25772760
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity.
Choi S; Lee SA; Kwak TK; Kim HJ; Lee MJ; Ye SK; Kim SH; Kim S; Lee JW
Blood; 2009 Feb; 113(8):1845-55. PubMed ID: 19036703
[TBL] [Abstract][Full Text] [Related]
4. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).
Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW
Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
8. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
9. The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.
Jung O; Choi YJ; Kwak TK; Kang M; Lee MS; Ryu J; Kim HJ; Lee JW
Biochim Biophys Acta; 2013 Mar; 1833(3):629-42. PubMed ID: 23220047
[TBL] [Abstract][Full Text] [Related]
10. N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application.
Song HE; Lee Y; Kim E; Cho CY; Jung O; Lee D; Lee EG; Nam SH; Kang M; Macalino SJY; Kim JE; Jung JW; Kwon SW; Choi S; Lee JW
Theranostics; 2021; 11(16):8092-8111. PubMed ID: 34335982
[TBL] [Abstract][Full Text] [Related]
11. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
[TBL] [Abstract][Full Text] [Related]
12. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases.
Lee JW
Int Rev Cell Mol Biol; 2015; 319():141-63. PubMed ID: 26404468
[TBL] [Abstract][Full Text] [Related]
16. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW
Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774
[TBL] [Abstract][Full Text] [Related]
18. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.
Lin L; Jou D; Wang Y; Ma H; Liu T; Fuchs J; Li PK; Lü J; Li C; Lin J
Int J Oncol; 2016 Dec; 49(6):2265-2274. PubMed ID: 27748818
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
